Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome

MeSH terms

• Blindness, Cortical / chemically induced*
• Blood Group Incompatibility / drug therapy*
• Blood Group Incompatibility / immunology
• Calcineurin Inhibitors / adverse effects*
• Calcineurin Inhibitors / therapeutic use
• Carcinoma, Hepatocellular / etiology
• Carcinoma, Hepatocellular / surgery
• Confusion / chemically induced*
• Drug Substitution
• Drug Therapy, Combination
• Emergencies
• Everolimus
• Graft Rejection / prevention & control*
• Graft Rejection / therapy
• Hepatitis B, Chronic / complications
• Humans
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use*
• Liver Cirrhosis / etiology
• Liver Cirrhosis / surgery
• Liver Neoplasms / etiology
• Liver Neoplasms / surgery
• Liver Transplantation* / adverse effects
• Male
• Middle Aged
• Photopheresis
• Plasmapheresis
• Sirolimus / analogs & derivatives*
• Sirolimus / therapeutic use
• Syndrome
• Tacrolimus / adverse effects*
• Tacrolimus / therapeutic use